Aberrant alternative splicing (AS) has been highly involved in the tumorigenesis and progression of most cancers. The potential role of AS in invasive breast cancer (IBC) remains largely unknown. In this study, RNA sequencing of IBC samples from The Cancer Genome Atlas was acquired …

Source: http://feeds.nature.com/~r/srep/rss/current/~3/fb46DUk1eKc/s41598-020-73700-1

Leave a Reply

Your email address will not be published.